2020
DOI: 10.1101/2020.04.22.054908
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Investigating regions of shared genetic variation in attention deficit/hyperactivity disorder and major depressive disorder: A GWAS meta-analysis

Abstract: Attention deficit/hyperactivity disorder (ADHD) demonstrates a high level of comorbidity with major depressive disorder (MDD). One possible contributor to this is that the two disorders show high genetic correlation. However, the specific regions of the genome that may be responsible for this overlap are unclear. To identify variants associated with both ADHD and MDD, we performed a meta-analysis of GWAS of ADHD and MDD. All genome wide significant (p=5x10 -8 ) SNPs in the meta-analysis that were also strongly… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 41 publications
(48 reference statements)
1
1
0
Order By: Relevance
“…The second strongest signal we identified was rs12658032 (P = 3.77 x 10-19), located in the intron of lincRNA RP11-6N13.1. This locus was not reported by Wray et al [16] or Lane et al [21] but was shown to be associated with MDD and attention deficit/hyperactivity disorder (ADHD) [41]. The third significant SNP was rs12552 (P = 5.69 x 10-16) in the 3'UTR of OLFM4, which was also reported in Wray et al [16] (Supplementary Fig.…”
Section: Shared Genetic Variantssupporting
confidence: 52%
“…The second strongest signal we identified was rs12658032 (P = 3.77 x 10-19), located in the intron of lincRNA RP11-6N13.1. This locus was not reported by Wray et al [16] or Lane et al [21] but was shown to be associated with MDD and attention deficit/hyperactivity disorder (ADHD) [41]. The third significant SNP was rs12552 (P = 5.69 x 10-16) in the 3'UTR of OLFM4, which was also reported in Wray et al [16] (Supplementary Fig.…”
Section: Shared Genetic Variantssupporting
confidence: 52%
“…Two GWAS meta-analyses by the Cross-Disorder Group of the Psychiatric Genomics Consortium that examined associations in five and eight psychiatric disorders have demonstrated genetic correlations of similar strengths between ADHD and MDD to those reported in other meta-analysis studies, along with identification of associations of single nucleotide polymorphisms (SNPs) on chromosomes 3p21 and 10q24 and CACNB2, the gene encoding a voltage-gated L-type calcium channel, suggesting that L-type calcium channels could be a candidate molecule linking MDD and ADHD ( Cross-Disorder Group of the Psychiatric Genomics Consortium, 2013 , 2019 ). A GWAS meta-analysis by Powell et al also compared ADHD and MDD, identifying 14 SNPs with concordant directions of effect for both disorders, with the estimated genetic correlation being r g = 0.52 ( Powell et al, 2021 ).…”
Section: Genetic Correlations Between Adhd and Mddmentioning
confidence: 99%